Impact of OCT on Outcomes in AMI
Impact of Optical Coherence Tomography on Long-term Clincal Outcomes in Patients With Acute Myocardial Infarction
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jincheng Guo, M.D.
- Phone Number: 8610-13521968844
- Email: guojcmd@126.com
Study Locations
-
-
-
Beijing, China, 100000
- Recruiting
- Beijing Luhe Hospital
-
Contact:
- Jincheng Guo, M.D.
- Phone Number: 8610-13521968844
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age≥18 years old
- Patients undergo cardiac catheterization and percutaneous coronary intervention(PCI) for AMI(STEMI or NSTEMI) ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction, symptoms onset≤ 24h.NSTEMI was defined as elevated troponin levels and the absence of ST elevation at the time of diagnosis, PCI was performed within 24hours after symtoms onset.
- Sufficient quality of the OCT recording allowing for CoreLab analysis.
Exclusion Criteria:
- ostial of Left main disease
- Cardiogenic shock or severe hemodynamic instability
- Severe renal insufficiency (creatinine clearance ≤30 mL/min)
- Bacteraemia or septicaemia
- Severe coagulation disorders
- Patients with life expectancy less than 1 year
- Patients who refuse to sign the informed consent form
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
OCT guided group
|
patients were divided into two groups,on OCT guided coronary group and coronary angiography guided group
|
|
angiography guided group
|
patients were divided into two groups,on OCT guided coronary group and coronary angiography guided group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
major adverse cardiovascular event
Time Frame: 3 year
|
including cardiovascualr death, myocardial infarction, and target lesion revascularization, target vessel revascularization
|
3 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BeijngLH
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.